SEC Form 4 · accession 0001013606-16-000325
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shari L O'Quinn
Officer — VP, Clinical & Regulatory
Period of report
Dec 9, 2016
Accepted (ET)
Dec 13, 2016 · 11:59 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Dec 9, 2016 | A | 21,834 | $0.00 | A | 76,356 | D |
Table II — derivative securities
No Table II lines on this filing.